$RNVA
Rennova Health, Inc. Stock $rnva

$rnva Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223028849 Filed on August 15, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$3.500M	$6.400M	$3.600M
YoY Change	25.0%	77.78%	300.0%
Cost Of Revenue	$1.807M	$1.834M	$1.572M
YoY Change	-0.93%	16.7%	23.82%
Gross Profit	$1.693M	$4.566M	$2.028M
YoY Change	73.42%	125.11%	-649.23%
Gross Profit Margin	48.39%	71.34%	56.34%
Selling, General & Admin	$2.276M	$2.359M	$1.880M
YoY Change	25.74%	25.45%	-10.72%
% of Gross Profit	134.38%	51.66%	92.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$56.80K	$99.36K	$117.2K
YoY Change	-51.64%	-15.24%	-39.47%
% of Gross Profit	3.35%	2.18%	5.78%
Operating Expenses	$2.333M	$2.458M	$1.997M
YoY Change	21.03%	23.07%	-13.14%
Operating Profit	-$601.0K	$2.097M	$37.18K
YoY Change	-35.02%	5540.12%	-101.41%
Interest Expense	$36.46K	-$431.5K	-$479.3K
YoY Change	-106.02%	-9.97%	-46.14%
% of Operating Profit		-20.58%	-1289.0%
Other Income/Expense, Net	-$138.6K	-$295.4K	-$537.0K
YoY Change	-66.61%	-44.99%	-146.7%
Pretax Income	-$739.6K	$1.802M	-$499.8K
YoY Change	-44.8%	-460.43%	-66.46%
Income Tax	-$184.5K	$517.0K
% Of Pretax Income		28.7%
Net Earnings	-$500.0K	$1.278M	-$503.8K
YoY Change	-62.73%	-353.65%	-105.55%
Net Earnings / Revenue	-14.29%	19.97%	-13.99%
Basic Earnings Per Share	$0.00	$0.00	-$0.11
Diluted Earnings Per Share	$0.00	$0.00	-$296.00
COMMON SHARES
Basic Shares Outstanding	29.93B shares	29.93B shares	1.702B shares
Diluted Shares Outstanding	31.40B shares	482.1B shares	1.702B shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$123.9K	$725.5K	$126.9K
YoY Change	1030.47%	471.82%	-36.44%
Cash & Equivalents	$123.9K	$725.5K	$126.9K
Short-Term Investments
Other Short-Term Assets	$156.3K	$383.5K	$100.6K
YoY Change	33.77%	281.32%	-42.58%
Inventory	$266.0K	$235.4K	$243.6K
Prepaid Expenses
Receivables	$1.791M	$2.881M	$2.211M
Other Receivables	$3.340M	$2.334M	$1.943M
Total Short-Term Assets	$5.677M	$7.397M	$4.625M
YoY Change	-2.67%	59.96%	130.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.268M	$4.278M	$4.429M
YoY Change	-1.04%	-3.42%	-47.44%
Goodwill
YoY Change
Intangibles	$259.4K	$259.4K	$259.4K
YoY Change	0.0%	0.0%
Long-Term Investments	$9.016M	$9.016M	$9.016M
YoY Change	0.0%	0.0%	6.07%
Other Assets	$224.4K	$164.4K	$197.8K
YoY Change	-1.49%	-16.88%	-54.47%
Total Long-Term Assets	$14.17M	$14.16M	$14.61M
YoY Change	-1.99%	-3.07%	-17.11%
TOTAL ASSETS
Total Short-Term Assets	$5.677M	$7.397M	$4.625M
Total Long-Term Assets	$14.17M	$14.16M	$14.61M
Total Assets	$19.85M	$21.56M	$19.23M
YoY Change	-2.18%	12.09%	-2.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.12M	$13.01M	$12.12M
YoY Change	-2.09%	7.36%	-24.12%
Accrued Expenses	$19.46M	$19.32M	$17.28M
YoY Change	0.56%	11.82%	-5.04%
Deferred Revenue
YoY Change
Short-Term Debt	$8.222M	$8.222M	$0.00
YoY Change	0.0%		-100.0%
Long-Term Debt Due	$11.61M	$11.79M	$14.24M
YoY Change	-19.17%	-17.21%	-35.14%
Total Short-Term Liabilities	$47.19M	$48.30M	$47.35M
YoY Change	-5.25%	2.01%	-20.39%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities	$225.0K	$271.6K	$456.4K
YoY Change	-43.88%	-40.5%	-34.1%
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$47.19M	$48.30M	$47.35M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$47.41M	$48.57M	$47.80M
YoY Change	-5.56%	1.6%	-21.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.702B	-$1.701B	-$1.703B
YoY Change	-0.14%	-0.09%
Common Stock	$3.705M	$2.993M	$422.5K
YoY Change	145.47%	608.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$27.60M	-$27.00M	-$28.60M
YoY Change
Total Liabilities & Shareholders Equity	$19.85M	$21.56M	$19.23M
YoY Change	-2.18%	12.09%	-2.01%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$500.0K	$1.278M	-$503.8K
YoY Change	-62.73%	-353.65%	-105.55%
Depreciation, Depletion And Amortization	$56.80K	$99.36K	$117.2K
YoY Change	-51.64%	-15.24%	-39.47%
Cash From Operating Activities	-$244.5K	$2.206M	-$58.48K
YoY Change	-661.2%	-3871.67%	-97.77%
INVESTING ACTIVITIES
Capital Expenditures	$46.55K	$56.53K	-$33.94K
YoY Change	5376.47%	-266.56%	-57.64%
Acquisitions
YoY Change
Other Investing Activities	-$131.8K	-$563.2K	-$428.9K
YoY Change	17.23%	31.29%
Cash From Investing Activities	-$178.3K	-$619.7K	-$462.9K
YoY Change	127.28%	33.87%	477.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-178.9K	-1.112M	545.0K
YoY Change	120.73%	-304.0%	-80.72%
NET CHANGE
Cash From Operating Activities	-244.5K	2.206M	-58.48K
Cash From Investing Activities	-178.3K	-619.7K	-462.9K
Cash From Financing Activities	-178.9K	-1.112M	545.0K
Net Change In Cash	-601.6K	474.3K	23.59K
YoY Change	419.0%	1910.6%	-81.56%
FREE CASH FLOW
Cash From Operating Activities	-$244.5K	$2.206M	-$58.48K
Capital Expenditures	$46.55K	$56.53K	-$33.94K
Free Cash Flow	-$291.0K	$2.149M	-$24.54K
YoY Change	-781.36%	-8857.7%	-99.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	97681	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000931059
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2023Q2	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q1	RNVA	Stock Issued During Period Value Conversion Of Series O Preferred Stock Into Common Stock StockIssuedDuringPeriodValueConversionOfSeriesOPreferredStockIntoCommonStock		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q2	RNVA	Stock Issued During Period Value Conversion Of Series O Preferred Stock Into Common Stock StockIssuedDuringPeriodValueConversionOfSeriesOPreferredStockIntoCommonStock		usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	RNVA	Payments Of Accounts Receivable Sold Under Sales Agreements PaymentsOfAccountsReceivableSoldUnderSalesAgreements		usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
	RNVA	Proceeds From Hhs Provider Relief Funds ProceedsFromHhsProviderReliefFunds		usd
	RNVA	Cash Paid For Fractional Shares In Connection With Reverse Stock Split CashPaidForFractionalSharesInConnectionWithReverseStockSplit		usd
CY2023Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q2	RNVA	Property Plant And Equipment And Finance Lease Right Of Use Asset PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAsset		usd
CY2022Q4	RNVA	Property Plant And Equipment And Finance Lease Right Of Use Asset PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAsset		usd
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
	RNVA	Finance Lease Payments FinanceLeasePayments		usd
	RNVA	Finance Lease Payments FinanceLeasePayments		usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	RNVA	Deemed Dividends From Exchanges Of Debt For Preferred Stock DeemedDividendsFromExchangesOfDebtForPreferredStock		usd
	RNVA	Deemed Dividends For Trigger Of Down Round Provisions DeemedDividendsForTriggerOfDownRoundProvisions		usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense		usd
	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense		usd
CY2023Q2	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
CY2022Q2	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35141
	dei	Entity Registrant Name EntityRegistrantName	RENNOVA HEALTH, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	68-0370244
	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 S. Australian Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 800
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
	dei	City Area Code CityAreaCode	(561)
	dei	Local Phone Number LocalPhoneNumber	855-1626
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29934322257	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	725517	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	499470	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2881150	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3110969	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2334251	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1457253	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	235365	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	242645	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	383526	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	215365	usd
CY2023Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	837460	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	837460	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	7397269	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6363162	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4277790	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4194299	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	259443	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	259443	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	9016072	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	9016072	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	164413	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	165530	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	440310	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	574256	usd
CY2023Q2	us-gaap	Assets Assets	21555297	usd
CY2022Q4	us-gaap	Assets Assets	20572762	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	13008981	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11514322	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19319575	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19563808	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1865425	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1348425	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1318315	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2917390	usd
CY2023Q2	us-gaap	Loans Payable LoansPayable	2253000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	2995000	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	8222240	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	8622240	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	168761	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	215063	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	455336	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	455336	usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1464209	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1456112	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	48296303	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	49308157	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	271549	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359193	usd
CY2023Q2	us-gaap	Liabilities Liabilities	48567852	usd
CY2022Q4	us-gaap	Liabilities Liabilities	49667350	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29934322257	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29934322257	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29084322257	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29084322257	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2993432	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2908432	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1671486835	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1671571834	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1701494387	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1703577780	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-27011195	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-29094588	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	-1360	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27012555	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-29094588	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21555297	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20572762	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6389219	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3606236	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11305115	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4750756	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1834107	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1571673	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3687153	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2946316	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2358758	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1880167	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4575428	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3452503	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	99357	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	117216	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	193492	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	234040	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	4292222	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	3569056	usd
	us-gaap	Costs And Expenses CostsAndExpenses	8456073	usd
	us-gaap	Costs And Expenses CostsAndExpenses	6632859	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2096997	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	37180	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2849042	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1882103	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	212368	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-316369	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	255114	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-42281	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	200000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	334819	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	200000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	334819	usd
CY2023Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-276313	usd
CY2022Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-76218	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	286719	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-76218	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	431484	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	479253	usd
	us-gaap	Interest Expense Other InterestExpenseOther	983747	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1100190	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-295429	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-537021	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-241914	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-883870	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1801568	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-499841	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2607128	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2765973	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	517000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	517000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1284568	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-499841	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2090128	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2765973	usd
CY2023Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-8097	usd
CY2022Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-3945	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-8097	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-5379	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	1276471	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-503786	usd
	us-gaap	Profit Loss ProfitLoss	2082031	usd
	us-gaap	Profit Loss ProfitLoss	-2771352	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1362	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1362	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1277833	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-503786	usd
	us-gaap	Net Income Loss NetIncomeLoss	2083393	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2771352	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	194951624	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	330876369	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1277833	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-195455410	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2083393	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-333647721	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.11
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.39
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.00
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.11
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.00
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.39
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29934322257	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1702149425	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29845095738	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	858169865	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	482079733368	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1702149425	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	488414836833	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	858169865	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-29094588	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	805560	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28289028	usd
CY2023Q2	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	2	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	1276471	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27012555	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27301524	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27301524	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000000	usd
CY2022Q1	RNVA	Stock Issued During Period Value Payment Of Cash In Lieu Of Fractional Shares StockIssuedDuringPeriodValuePaymentOfCashInLieuOfFractionalShares	9	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2267566	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2267566	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28569099	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28569099	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	500000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-503786	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-503786	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28572885	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28572885	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2090128	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2765973	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	193492	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	234040	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-858	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	286719	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-76218	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	200000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	334819	usd
	RNVA	Income Loss From Discontinued Operation Net Of Tax IncomeLossFromDiscontinuedOperationNetOfTax	8097	usd
	RNVA	Income Loss From Discontinued Operation Net Of Tax IncomeLossFromDiscontinuedOperationNetOfTax	5379	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-229819	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-186131	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7280	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-36890	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	168159	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-21304	usd
	RNVA	Increase Decrease In Security Deposit IncreaseDecreaseInSecurityDeposit	-1117	usd
	RNVA	Increase Decrease In Security Deposit IncreaseDecreaseInSecurityDeposit	10000	usd
	RNVA	Increase Decrease Right Of Use Asset IncreaseDecreaseRightOfUseAsset	-133946	usd
	RNVA	Increase Decrease Right Of Use Asset IncreaseDecreaseRightOfUseAsset	-117871	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1494659	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	484458	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-531720	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	867828	usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	517000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-133946	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-117871	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3338800	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1208444	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	8097	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1714	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3346897	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1210158	usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	876998	usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	428943	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	276983	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33940	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1153981	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-462883	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	580000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	750000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1322000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	400000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	824869	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1171603	usd
	RNVA	Payments Of Accounts Receivable Sold Under Sales Agreements PaymentsOfAccountsReceivableSoldUnderSalesAgreements	-317647	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	1500000	usd
	RNVA	Proceeds From Hhs Provider Relief Funds ProceedsFromHhsProviderReliefFunds	314651	usd
	RNVA	Cash Paid For Fractional Shares In Connection With Reverse Stock Split CashPaidForFractionalSharesInConnectionWithReverseStockSplit	9	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1966869	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1075392	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	226047	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-597649	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	499470	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	724524	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	725517	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	126875	usd
CY2022Q2	RNVA	Allowance For Adjustment Of Revenue AllowanceForAdjustmentOfRevenue	7800000	usd
CY2023Q2	us-gaap	Revenues Revenues	6400000	usd
CY2022Q2	us-gaap	Revenues Revenues	3600000	usd
	RNVA	Estimated Contractual Allowance EstimatedContractualAllowance	19600000	usd
	RNVA	Estimated Contractual Allowance EstimatedContractualAllowance	13200000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_z2qWOEhyBG77" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zKbxdgdpBj5d">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of net revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include the estimates of fair values of assets acquired and liabilities assumed in business combinations, contractual allowances and bad debt reserves, the recoverability of long-lived assets, the valuation allowance relating to the Company’s deferred tax assets, the valuations of investments, equity and derivative instruments, deemed dividends, litigation and related reserves, among others. Actual results could differ from those estimates and would impact future results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zJGhWSAMbWGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zvNVsqPtkuw5">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts have been reclassified to conform to the current year presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	RNVA	Estimated Contractual Allowance EstimatedContractualAllowance	8500000	usd
CY2022Q2	RNVA	Estimated Contractual Allowance EstimatedContractualAllowance	5100000	usd
CY2023Q2	RNVA	Estimated Implicit Price Concession EstimatedImplicitPriceConcession	1400000	usd
CY2022Q2	RNVA	Estimated Implicit Price Concession EstimatedImplicitPriceConcession	2700000	usd
CY2023Q2	RNVA	Allowance For Adjustment Of Revenue AllowanceForAdjustmentOfRevenue	9900000	usd
	RNVA	Estimated Implicit Price Concession EstimatedImplicitPriceConcession	2400000	usd
	RNVA	Estimated Implicit Price Concession EstimatedImplicitPriceConcession	4100000	usd
	RNVA	Allowance For Adjustment Of Revenue AllowanceForAdjustmentOfRevenue	22000000.0	usd
	RNVA	Allowance For Adjustment Of Revenue AllowanceForAdjustmentOfRevenue	17300000	usd
	us-gaap	Revenues Revenues	11300000	usd
	us-gaap	Revenues Revenues	4800000	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.052
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.052
CY2023Q2	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	0	usd
	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	0	usd
CY2022Q2	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	194700000	usd
	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	330500000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-5379	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1277833	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-195455410	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2083393	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-333647721	usd
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10,000
CY2022Q1	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	10000	shares
CY2023Q2	RNVA	Working Capital Deficit WorkingCapitalDeficit	40900000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-27000000.0	usd
	us-gaap	Net Income Loss NetIncomeLoss	2100000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3300000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1285930	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-499841	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2091490	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2765973	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	194951624	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	330876369	usd
CY2023Q2	RNVA	Net Loss Available To Common Shareholders Continuing Operations NetLossAvailableToCommonShareholdersContinuingOperations	1285930	usd
CY2022Q2	RNVA	Net Loss Available To Common Shareholders Continuing Operations NetLossAvailableToCommonShareholdersContinuingOperations	-195451465	usd
	RNVA	Net Loss Available To Common Shareholders Continuing Operations NetLossAvailableToCommonShareholdersContinuingOperations	2091490	usd
	RNVA	Net Loss Available To Common Shareholders Continuing Operations NetLossAvailableToCommonShareholdersContinuingOperations	-333642342	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-8097	usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-3945	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-8097	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29934322257	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1702149425	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29845095738	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	858169865	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6335103465	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	452145411111	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	452234637630	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	482079733368	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1702149425	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	488414836833	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	858169865	shares
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.11
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.39
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.00
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.11
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.00
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.39
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	540111184448	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1017687817790	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	533776080983	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1017687817790	shares
CY2023Q2	RNVA	Overpayment Reserve Current OverpaymentReserveCurrent	990062	usd
CY2022Q4	RNVA	Overpayment Reserve Current OverpaymentReserveCurrent	2101837	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2644351	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2105516	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19319575	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19563808	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	7300000	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	12268792	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	13046646	usd
CY2023Q2	RNVA	Allowance For Contractual Obligations AllowanceForContractualObligations	8190137	usd
CY2022Q4	RNVA	Allowance For Contractual Obligations AllowanceForContractualObligations	8529904	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1197505	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1405773	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2881150	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3110969	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8327011	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8533710	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	552099	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	552099	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	6308052	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	5736096	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	498000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	534550	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	7000000.0	usd
CY2022Q4	RNVA	Overpayment Reserve Current OverpaymentReserveCurrent	2100000	usd
	RNVA	Reduction In Overpayment Reserve ReductionInOverpaymentReserve	1100000	usd
CY2023Q2	RNVA	Overpayment Reserve Current OverpaymentReserveCurrent	1000000.0	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1318315	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2917390	usd
CY2023Q2	us-gaap	Loans Payable LoansPayable	2253000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	2995000	usd
CY2023Q2	RNVA	Debt Current Excluding Notes Payable DebtCurrentExcludingNotesPayable	8222240	usd
CY2022Q4	RNVA	Debt Current Excluding Notes Payable DebtCurrentExcludingNotesPayable	8622240	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	11793555	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	14534630	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	11793555	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	14534630	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	1318315	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	2917390	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1318315	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2917390	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	165039	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	82347	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	97681	usd
	us-gaap	Lease Cost LeaseCost	174915	usd
	us-gaap	Lease Cost LeaseCost	165039	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	175460	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	162539	usd
CY2023Q2	RNVA	Future Minimum Lease Payments Including Accrued Interest FutureMinimumLeasePaymentsIncludingAccruedInterest	200000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	440310	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	574256	usd
CY2023Q2	RNVA	Lease Assets LeaseAssets	440310	usd
CY2022Q4	RNVA	Lease Assets LeaseAssets	574256	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	168761	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	215063	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	271549	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359193	usd
CY2023Q2	RNVA	Lease Liabilities LeaseLiabilities	660771	usd
CY2022Q4	RNVA	Lease Liabilities LeaseLiabilities	794717	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M29D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M2D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.130	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.130	pure
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.049	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.049	pure
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	82347	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	174915	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	165039	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	82347	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	97681	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	174915	usd
CY2022Q4	RNVA	Future Minimum Lease Payments Including Accrued Interest FutureMinimumLeasePaymentsIncludingAccruedInterest	200000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	216239	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	224252	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	222712	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	74598	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	513549	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	224252	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	73239	usd
CY2023Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3791	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	440310	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	220461	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	168761	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	271549	usd
	RNVA	Percentage Of Market Price PercentageOfMarketPrice	0.85	pure
CY2023Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2022Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2022	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2022Q2	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	194700000	usd
	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	330500000	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.90	pure
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29900000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29900000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29100000000	shares
	us-gaap	Interest Paid Net InterestPaidNet	411791	usd
	us-gaap	Interest Paid Net InterestPaidNet	944082	usd
	RNVA	Conversion Of Preferred Stock Into Common Stock One ConversionOfPreferredStockIntoCommonStockOne	36000	usd
	RNVA	Conversion Of Preferred Stock Into Common Stock One ConversionOfPreferredStockIntoCommonStockOne	1833712	usd
	RNVA	Conversion Of Preferred Stock Into Common Stock Two ConversionOfPreferredStockIntoCommonStockTwo	40500	usd
	RNVA	Conversion Of Preferred Stock Into Common Stock Two ConversionOfPreferredStockIntoCommonStockTwo	179460	usd
	RNVA	Deemed Dividends From Exchanges Of Debt For Preferred Stock DeemedDividendsFromExchangesOfDebtForPreferredStock	333333	usd
	RNVA	Deemed Dividends For Trigger Of Down Round Provisions DeemedDividendsForTriggerOfDownRoundProvisions	330543036	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	1115066	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	1115066	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent	349143	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent	341046	usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1464209	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1456112	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	2811	usd
	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	4245	usd
CY2023Q2	RNVA	Disposal Group Including Discontinued Operation Other Income Expenses DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenses	-8097	usd
CY2022Q2	RNVA	Disposal Group Including Discontinued Operation Other Income Expenses DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenses	-1134	usd
	RNVA	Disposal Group Including Discontinued Operation Other Income Expenses DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenses	-8097	usd
	RNVA	Disposal Group Including Discontinued Operation Other Income Expenses DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenses	-1134	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-8097	usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-3945	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-8097	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-5379	usd

Files In Submission

Name	View Source	Status
0001493152-23-028849-index-headers.html	Edgar Link	pending
0001493152-23-028849-index.html	Edgar Link	pending
0001493152-23-028849.txt	Edgar Link	pending
0001493152-23-028849-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rnva-20230630.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rnva-20230630_cal.xml	Edgar Link	unprocessable
rnva-20230630_def.xml	Edgar Link	unprocessable
rnva-20230630_lab.xml	Edgar Link	unprocessable
rnva-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RNVA
Rennova Health, Inc. Stock $rnva

2023 Q3 Form 10-Q Financial Statement

#000149315223028849 Filed on August 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNVA Rennova Health, Inc. Stock $rnva

2023 Q3 Form 10-Q Financial Statement

#000149315223028849 Filed on August 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNVA
Rennova Health, Inc. Stock $rnva